| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,113 | 371 | 1,202 | 242 | | Cost of Revenue | 451 | 124 | 521 | 10 | | | Gross Profit | 662 | 247 | 681 | 232 | | | Operating Expenses | | Research Development | 3,513 | 3,539 | 4,093 | 6,183 | | Selling General and Administrative | 3,145 | 2,732 | 2,851 | 3,722 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (5,996) | (6,024) | (6,263) | (9,673) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (705) | 22 | 40 | 63 | | Earnings Before Interest And Taxes | (6,701) | (6,002) | (6,223) | (9,610) | | Interest Expense | 246 | 275 | 305 | 901 | | Income Before Tax | (6,947) | (6,277) | (6,528) | (10,511) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (6,947) | (6,277) | (6,528) | (10,511) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (6,947) | (6,277) | (6,528) | (10,511) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($6,947) | ($6,277) | ($6,528) | ($10,511) |
|
0.02% Nasdaq 0.00%
Income Statement
